Poster Tour 05: Bridging the Gaps: Increasing Access and Continuity of Care
Tracks
Track 3
| Friday, October 17, 2025 |
| 11:10 AM - 11:35 AM |
| Hall D |
Speaker
Mr Tony Kelly
Research And Data Analyst
RECAP Health Services
PERSON-CENTRED CARE AS A PRIMARY APPROACH TO HARM REDUCTION IN ADDICTION AND INFECTIOUS DISEASE TREATMENT IN NEW BRUNSWICK, CANADA.
11:10 AM - 11:15 AMBiography
Tony is a master's student at Yorkville University in the field of counseling psychology. He is a community activist for PWUD and studies models of care, treatment engagement, and psychodynamic treatment approaches to addiction. His epistemological stance emphasizes relativistic perspectives with an existential philosophy that focuses on person-centred modalities.
Mrs Yevheniia Zakrevska
Senior Program Manager
Icf "Alliance For Public Health"
LOW RETENTION OF FEMALE PATIENTS ON OAT TREATMENT, UKRAINE'S EXPERIENCE DURING THE WAR
11:15 AM - 11:20 AMBiography
I"m working in the field of public health, in field of Opioid Agonist Treatment (OAT). Currently, is a senior project manager at the ICF "Alliance for Public Health", working on the expansion and development of programs for PWID.
Prof. Dr. Philip Bruggmann
Co-Head of Internal Medicine
Arud Centre for Addiction Medicine
INTEGRATED CARE APPROACHES FOR ANABOLIC STEROID USE DISORDER: A SWISS PERSPECTIVE ON PUBLIC HEALTH AND HARM REDUCTION
11:20 AM - 11:25 AMBiography
Philip Bruggmann is co-head of internal medicine at Arud in Zurich, one of the largest outpatient clinics for addiction medicine in Europe.
He co-founded INHSU and served as its first president.
Philip is a professor at the Institute of Family Medicine of the University of Zurich.
Dr Emmanuel Clement
Doctoral Student
University of Port Harcourt School of Public Health
Prevalence, treatment outcomes, and elimination strategy of Hepatitis C among PWIDs in the oil spill-impacted communities, Niger Delta, Nigeria
11:25 AM - 11:30 AMBiography
I am Emmanuel Clement, a serial public health researcher with interest in HIV, hepatitis, TB and the well-being of key populations, especially people who inject drugs. I have had many abstracts accepted at international conferences like IAS and the HIV Prevention Conference in Munich and Peru, though I didn't have a scholarship to attend.
Tour Guide
Joshua Dawe
PhD Researcher
University of Bristol